Rivastigmine transdermal patch

Be sure to remove the patch before you apply another one. Do not apply a patch to the same spot for at least 14 days. If the patch loosens or falls off, replace it with a new patch.

However, you should remove the new patch at the time that you were scheduled to remove the original patch. While you are wearing a rivastigmine patch, protect the patch from direct heat such as heating pads, electric blankets, heat lamps, saunas, hot tubs, and heated water beds. Do not expose the patch to direct sunlight for very long. This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Apply the missed patch as soon as you remember it. However, you should still remove the patch at your regular patch removal time. If it is almost time for the next patch, skip the missed patch and continue your regular dosing schedule. Do not apply extra patches to make up for a missed dose. Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture not in the bathroom. Dispose of any patches that are outdated or no longer needed by opening each pouch, folding each patch in half with the sticky sides together.

Place the folded patch in the original pouch and dispose of it safely, out of the reach of children and pets. Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them.

However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. It is important to keep all medication out of sight and reach of children as many containers such as weekly pill minders and those for eye drops, creams, patches, and inhalers are not child-resistant and young children can open them easily.

To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location — one that is up and away and out of their sight and reach. If someone applies extra or a higher dosage of rivastigmine patches but does not have any of the symptoms listed below, remove the patch or patches.

Call your doctor and do not apply any additional patches for the next 24 hours. It is important for you to keep a written list of all of the prescription and nonprescription over-the-counter medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements.

You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Rivastigmine Transdermal Patch pronounced as ri va stig' meen. Why is this medication prescribed? How should this medicine be used? Other uses for this medicine What special precautions should I follow? What special dietary instructions should I follow? What should I do if I forget a dose?

What side effects can this medication cause? What should I know about storage and disposal of this medication? Brand names. To apply the patch, follow these steps: Choose the area where you will apply the patch. Wash the area with soap and warm water. Rinse off all of the soap and dry the area with a clean towel. Be sure the skin is free of powders, oil, and lotions.

Select a patch in a sealed pouch and cut open the pouch open with scissors. Be careful not to cut the patch. Remove the patch from the pouch and hold it with the protective liner facing you. Objective: To assess the potential role of a new transdermal TD formulation of rivastigmine in the management of Alzheimer's disease. Study selection and data extraction: All studies evaluating any aspect of TD rivastigmine, including in vivo animal experimentation.

Data synthesis: Rivastigmine is the first acetylcholinesterase inhibitor to be marketed in a TD formulation. Conclusion: Despite the advantages of TD rivastigmine just described, a number of questions still exist with this formulation. The effects of environmental factors on drug pharmacokinetics are unknown e. The TD formulation has not eliminated the need for titration to the target dose.